Clinical trials: Tourette Disorder
Tourette Syndrome
SCI-110 in the Treatment of Tourette Syndrome
To evaluate the efficacy, safety and tolerability of the cannabinoid-based medication SCI-110 compared to placebo in subjects with Tourette syndrome.
- Trial name
- NCT05126888
- Testing
- SCI-110
- Where
- 3 sites in United States, Germany and 1 more
- Volunteers
- 164 people
- Sponsor
- Neurothera Labs Inc.
Tourette Syndrome, Persistent Tic Disorder
Online Mindfulness-based Tic Reduction (Phase Two)
Tourette Syndrome (TS) and Persistent Tic Disorder (PTD) are chronic and potentially disabling neurobiological conditions. Although a range of pharmacological and psychosocial treatments exists, a significant number of…
- Trial name
- NCT03771235
- Testing
- Mindfulness-based Intervention for Tics, Tic Information and Coping Strategies
- Where
- 2 sites in United States
- Volunteers
- 37 people
- Sponsor
- Bowdoin College